Kingsbury Capital Investment Advisors LLC Alzamend Neuro, Inc. Transaction History

Kingsbury Capital Investment Advisors LLC

  • $65.6 Million
  • Q3 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$0.82 - $1.2 $11,102 - $16,248
13,540 Added 117.54%
25,059 $22,000
Q1 2022

May 16, 2022
BUY
$0.91 - $2.23 $10,482 - $25,687
11,519 New
11,519 $14,000

About Alzamend Neuro, Inc.

ALZN Quotes by TradingView
  • Ticker ALZN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,481,800
  • Market Cap $115M
  • Description
  • Alzamend Neuro, Inc., an early clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001 that is in Phase II clinical trial, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment ...
More about ALZN
Track This Portfolio

Track Kingsbury Capital Investment Advisors LLC Portfolio

Follow Kingsbury Capital Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsbury Capital Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsbury Capital Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email